Entyvio (vedolizumab)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Entyvio (vedolizumab), covering 2025-09-19 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab [Phase 3]